Stay updated with breaking news from Robert Tessarolo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
23.03.2022 - Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ... Seite 1
Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences
OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company focused on bringing
Completed concrete milestones in its strategy to become a leading psychedelic drug developer and specialty clinics operator. Developed clear drug development pathway for NEO-001, the industry's first psilocybin-based
Press release content from Accesswire. The AP news staff was not involved in its creation.